[ Price : $8.95]
Eye on FDA notes a reduction in the number of drug-related advisory committee meetings this year and whether this can be seen as l...[ Price : $8.95]
The Stericycle Expert Solutions third quarter recall index shows a lower number of prescription drug recalls and a very high numbe...[ Price : $8.95]
Braeburn says its Brixadi treatment for opioid use disorder is available to be marketed 12/1/20 after FDA revoked the orphan drug ...[ Price : $8.95]
FDA issues a guidance explaining the process to seek review of a Certificate to Foreign Government denial.[ Price : $8.95]
Ropes & Gray says the Supreme Court will consider whether the SEC has the legal authority to seek disgorgement as an enforcement t...[ Price : $8.95]
GlaxoSmithKline says it will seek approval for Nucala (mepolizumab) for treating patients living with Hypereosinophilic Syndrome b...[ Price : $8.95]
Federal Register notice: FDA announces a 12/6 public workshop on incorporating clinical outcome assessments into endpoints for reg...